Home

Prognosis

Anxiety, Depression

Read time: 4 min

Satellite symposium

Improving functioning as a treatment goal in comorbid major depressive disorder and generalized anxiety disorder

At the 35th ECNP Congress in Vienna, Austria (15−18th October), in a symposium...

Read time: 3 min

Satellite symposium

Key considerations for women living with schizophrenia

In this symposium presented at the 35th ECNP Congress in Vienna, Austria (15th−18th Oct),...

Read time: 8 min

Satellite symposium

Schizophrenia today: how important is the patient perspective?

At the 35th ECNP Congress in Vienna, Austria (15−18th Oct), in a symposium titled...

What are the common clinical challenges when diagnosing obsessive-compulsive disorder?

Professor Borwin Bandelow sat down with us to discuss how obsessive-compulsive disorder (OCD) can...

Read time: 5 min

Assessing the value of antidepressants in depression

In a session titled ‘Antidepressants in Depression: What Do They Do and How Do They Do It?...

Read time: 3 min

Congress highlights

Do early intervention services impact long-term outcomes in patients with psychosis?

Early intervention services (EIS) specifically designed to meet the needs of patients with early-...

Read time: 2 min

Congress highlights

Can we predict the future of patients with early-episode psychosis?

The ability to better predict patient outcomes would be highly valuable to clinicians, allowing the...

Read time: 2 min

Congress highlights

Can we predict conversion to first-episode psychosis?

A better understanding of the pre-psychotic and prodromal symptoms of psychosis can aid correct...

Neurotoriun

Neurotorium is your new point of reference for educational content on psychiatry, neurology, and neuroscience.

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind MENA Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind Greece Continue to Progress in Mind South East Asia Continue to Progress in Mind Middle East & Africa Continue to Progress in Mind United Kingdom Continue to Progress in Mind Sweden Continue to Progress in Mind Norge Continue to Progress in Mind Denmark Continue to Progress in Mind Japan RC Continue to Progress in Mind България Continue to Progress in Mind Israel Continue to Progress in Mind Sweden Continue to Progress in Mind Finland Continue to Progress in Mind Ukraine Continue to Progress in Mind Belgium & Luxembourg Continue to Progress in Mind Switzerland Continue to Progress in Mind Germany Continue to Progress in Mind Austria

You are leaving Progress in Mind

Continue to

Cancel

Progress in Mind Belux

Accept Cancel

Login as a registered health care professional

Please enter your email to continue

Register as a health care professional

Please enter your email to continue

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intended for health care professionals.

All the information included in the Website is related to diseases, investigations and existing or potential treatment options and, therefore, directed to health professionals . The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country